跳至主要内容
临床试验/CTRI/2026/02/104231
CTRI/2026/02/104231尚未招募2/3 期

Efficacy of Kulattha ghana vati in comparison to Gokshuradi guggulu in Mutrashmari-Urolithiasis - A Randomised clinical study

Dr Soundarya Shrishail Biradar1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2026年3月1日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
1. Reduction in the size of Mutrashmari.

研究概览

简要总结

A randomised clinical study on the efficacy of Kulattha ghana vati in Mutrashmari (Urolithiasis) in age group of 25 to 50 years for a period of 30 days. During this study period 30 subjects diagnosed with Mutrashmari (Urolithiasis) will be recruited and divided into two groups, Group A (Trial drug / Intervention drug) and Group B (Control drug / Comparator drug) 15 subjects in each group respectively.

Group A includes 15 subjects qualifying inclusion criteria of the current study will be administered Kulattha ghana vati internaly in the dose of 500 mg twice a day before food followed by jalapana and assessment of the patient during trial on 0th day, 15th day and 30th day. Group B includes 15 subjects qualifying inclusion criteria of the current study will be administered Gokshuradi guggulu internaly in the dose of 500 mg twice a day before food followed by jalapana and assessment of the patient during trial on 0th day, 15th day and 30th day. The outcome measures will be significant improvement noticed in Mutrashmari (Urolithiasis) after 30 days. Statistical analysis will be done through data obtained based on before and after treatment assessment.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
25.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Asymptomatic subjects who will be diagnosed with urolithiasis, detected accidentally by USG of Abdomen and pelvis. 2) Irrespective of gender, Socioeconomic status, religion and place. 3) Subjects aged between
  • 50 yrs. 4) Subjects with solitary or multiple calculi. 5) Stone location.
  • Kidney, ureter and bladder. 6) Size of stone within 10 days.

排除标准

  • Subjects suffering from Chronic kidney diseases.
  • Pregnant and Lactating mother.

结局指标

主要结局

1. Reduction in the size of Mutrashmari.

时间窗: 0th day(baseline), 15th day and 30 day

次要结局

  • Reduction in the Symptoms of patients like pain in abdomen /flank, haemeturia, Dysuria , UTIs(0th day(baseline), 15th day & 30th day)

研究者

发起方
Dr Soundarya Shrishail Biradar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Soundarya Shrishail Biradar

Sri Dharmasthala manjunatheshwara institute of Ayurveda and Hospital, Anchepalya, Kumbalagodu post , Bangalore

研究点 (1)

Loading locations...

相似试验